May 9, 2025 -- A new oral cancer drug combination has ... changes in blood test results (such as elevated liver enzyme and bilirubin levels, low hemoglobin levels and blood cell counts), eye ...

Itovebi plus Ibrance and Faslodex improved overall survival in patients with PIK3CA-mutant, HR+, HER2–, endocrine-resistant ...

Johnson & Johnson announced today first results from the Phase 3, randomized, double-blind, placebo-controlled AMPLITUDE study evaluating the combination of niraparib and abiraterone acetate plus ...

So is it time to add viruses to one's microbiome-feeding regimen of probiotics and prebiotics, synbiotics (which combine the ...

A low number ... such as the liver and kidneys — information that can be used later to determine the best treatment for your condition. Red blood cell tests may include a hemoglobin test or ...

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") and Pfizer Inc. today announced longer-term follow-up results from an open-label extension of the Phase 3 ARCHES ...

Yale researchers are providing new insights into how physical forces, such as cells being compressed in physically ...

The risk of dying from the most common form of primary liver cancer is about 30 percent higher for patients with low household income compared to those with middle or high household income ...

The risk of dying from the most common form of primary liver cancer is about 30 percent higher for patients with low household income compared to those with middle or high household income ...

Any thoughts on milk thistle supplements in fatty liver disease that was diagnosed by an ultrasound due to elevated AST and ...